In the event, the Kingston Chapter of the S2BN welcomed the head of JLABS Canada, Allan Miranda, to learn how to apply academic skills to the business world, discuss how to navigate through this world from a science perspective, and discover how scientific innovation can promote the life sciences sector.
Allan Miranda received his Ph.D. in Neuropharmacology from Queen's University at Kingston, Ontario and his MBA from McGill University in Finance and Strategy. He is currently the Head of Johnson & Johnson Innovation, JLABS in Canada. Allan is responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and P&L. He catalyzes and supports the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device, consumer and healthtech sectors.
Allan joined the JLABS team from Janssen Canada, where he has spent the last 12 years in positions of increasing responsibility in business development, marketing and market access. His most recent role was Therapeutic Lead Immunology and Primary Care where he was responsible for market access strategy for a complex product portfolio exceeding $1 billion. Allan started his career at PARTEQ Innovations, the technology transfer arm of Queen's University at Kingston where he was responsible for technology assessment and new company start-up. He then moved to Paladin Labs, where he successfully completed numerous in-licensing transactions for specialty pharmaceutical products for the Canadian market. Allan subsequently worked in business development for two early stage biotechnology companies in Canada leading their business development and partnering initiatives prior to joining Janssen.